4.7 Review

Role of ACE2 in pregnancy and potential implications for COVID-19 susceptibility

期刊

CLINICAL SCIENCE
卷 135, 期 15, 页码 1805-1824

出版社

PORTLAND PRESS LTD
DOI: 10.1042/CS20210284

关键词

-

资金

  1. Sao Paulo Research Foundation (FAPESP) [19/09745-5]
  2. SickKids Foundation [NI20-1037]
  3. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [19/09745-5] Funding Source: FAPESP

向作者/读者索取更多资源

This review explores the impact of SARS-CoV-2 infection on pregnancy, focusing on the role of ACE2 in viral entry and potential risks related to ACE2 changes in COVID-19 pregnancies. The study highlights the importance of understanding ACE2's functions in physiological systems during pregnancy and the necessity of filling knowledge gaps to improve management of high-risk pregnancies with COVID-19 exposure.
In times of coronavirus disease 2019 (COVID-19), the impact of severe acute respiratory syndrome (SARS)-coronavirus (CoV)-2 infection on pregnancy is still unclear. The presence of angiotensin-converting enzyme (ACE) 2 (ACE2), the main receptor for SARS-CoV-2, in human placentas indicates that this organ can be vulnerable for viral infection during pregnancy. However, for this to happen, additional molecular processes are critical to allow viral entry in cells, its replication and disease manifestation, particularly in the placenta and/or feto-maternal circulation. Beyond the risk of vertical transmission, COVID-19 is also proposed to deplete ACE2 protein and its biological actions in the placenta. It is postulated that such effects may impair essential processes during placentation and maternal hemodynamic adaptations in COVID-19 pregnancy, features also observed in several disorders of pregnancy. This review gathers information indicating risks and protective features related to ACE2 changes in COVID-19 pregnancies. First, we describe the mechanisms of SARS-CoV-2 infection having ACE2 as a main entry door and current evidence of viral infection in the placenta. Further, we discuss the central role of ACE2 in physiological systems such as the renin-angiotensin system (RAS) and the kallikrein-kinin system (KKS), both active during placentation and hemodynamic adaptations of pregnancy. Significant knowledge gaps are also identified and should be urgently filled to better understand the fate of ACE2 in COVID-19 pregnancies and the potential associated risks. Emerging knowledge will be able to improve the early stratification of high-risk pregnancies with COVID-19 exposure as well as to guide better management and follow-up of these mothers and their children.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据